Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,578.30 +0.45%
EUR-USD 1.2568 0.1014%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 91.32 +0.51%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

SNY:US

34.3100 USD 0.0800 0.23%

As of 20:04:06 ET on 05/25/2012.

Snapshot for Sanofi (SNY)

Open: 34.1000 Day's Range: 34.0600 - 34.4400 Volume: 3,713,843 Bid: 34.3200
Previous Close: 34.2300 52wk Range: 30.9800 - 40.5800 1-Yr Rtn: -7.17% Ask: 34.3300

Stock Chart for SNY

No chart data available.
  • SNY:US 34.3100
  • 1D
  • 1M
  • 1Y
34.2300
Interactive SNY Chart

Previous Close

Key Statistics for SNY

Current P/E Ratio (ttm) -
Estimated P/E (12/2012) 9.0869
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2012) 3.0170
Est. PEG Ratio 3.9508
Market Cap (M USD) 90,643.26
Shares Outstanding (M) 2,641.89
Enterprise Value (M EUR) (ttm) -
Enterprise Value/EBITDA (ttm) -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.9220
Next Earnings Announcement 07/26/2012
More SNY Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for SNY

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)
More SNY Income Statement Data
  • Total Assets
  • Total Liabilities (M/EUR)
  • Debt to Assets (%)
More SNY Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/EUR)
More SNY Cash Flow Data

Company Profile & Key Executives for SNY

Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Serge Daniel WeinbergChairmanChristopher A Viehbacher "Chris"Chief Executive Officer
Elias A ZerhouniPresident:Research & DevHanspeter SpekPresident:Global Operations
More Company Profile & Key Executives for SNY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements